The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

Phase 2 trial of enoblituzumab plus retifanlimab or tebotelimab in first-line treatment of patients (pts) with recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN).

Grzegorz  Obara

Employment - Comprehensive Cancer Centers of Nevada

Jichao  Sun

Employment - MacroGenics

Stock and Other Ownership Interests  - MacroGenics

Deryk  Loo

Employment - Macrogenics

Stock and Other Ownership Interests  - Macrogenics

Patents, Royalties, Other Intellectual Property - Author on patents submitted and published as an employee of MacroGenics, Inc. (Inst)

Gerry C.  Bohac

Employment - Macrogenics

Stock and Other Ownership Interests  - Amgen; Amgen; Macrogenics; Macrogenics; Macrogenics